A Case of Phrenic Nerve Paralysis During Adjuvant Chemotherapy for Rectal Cancer

Nobushige Yabe, Eri Tamura, Keiichiro Kitahama, Hiroki Ozawa, Yuki Tajima, Takashi Takenoya, Ippei Oto, Takahisa Yoshikawa, Kenji Kojima, Shinji Murai, Hirotoshi Hasegawa, Yuko Kitagawa

Research output: Contribution to journalArticle

Abstract

A man aged 66 years presented with pneumaturia as a major complaint. Cancer of the sigmoid colon with infiltration to the urinary bladder was diagnosed and the patient underwent colectomy of the sigmoid colon and partial cystectomy of the bladder in May 2015. Histopathologic examinations revealed pT4b, Si(bladder), pN(-), cM0, fStage II . Because intestinal sub-obstruction and lymphatic invasion were present, CapeOX was administered as an adjunctive chemotherapy for the high-risk Stage II cancer. Because Grade 2 peripheral neuropathy appeared as a side effect, the dose was decreased to 80% from the 3 cycle. After the 7 cycle, cough and disturbed breathing appeared. The chest CT scans did not reveal drug-induced interstitial pneumonia, but indicated an elevated right diaphragm and zosteroid changes in the medial lobe of the right lung due to discoid atelectatic condition. The Grade 1 respiratory symptoms were mild, and the lung field was considered to exhibit no problems. Thus, the 8 cycle was administered. The symptoms disappeared after about 2 weeks following completion of oral administration of capecitabine. The diaphragm also recovered to its original height. In the attached document, the frequency is unknown and "dyspnea" is written for L-OHP and capecitabine, respectively. It is unknown whether phrenic nerve paralysis occurs. However, because other organic lesions were absent and the symptoms appeared during chemotherapy, the possibility is not deniable. At present, 2 years postoperatively, recurrent lesions in the mediastinum and recurrent respiratory difficulties are absent. Generally, although phrenic nerve paralysis is not considered to be a specific side effect, it was considered that for respiratory difficulties, CT reveals not only the affected condition in the lung fields, but is also useful for detection.

Original languageEnglish
Pages (from-to)1916-1918
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume44
Issue number12
Publication statusPublished - 2017 Nov 1

Fingerprint

Phrenic Nerve
Adjuvant Chemotherapy
Rectal Neoplasms
Paralysis
Urinary Bladder
Diaphragm
Lung
Sigmoid Neoplasms
Drug Therapy
Colectomy
Intestinal Obstruction
Cystectomy
Interstitial Lung Diseases
Herpes Zoster
Mediastinum
Peripheral Nervous System Diseases
Sigmoid Colon
Cough
Dyspnea
Oral Administration

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Yabe, N., Tamura, E., Kitahama, K., Ozawa, H., Tajima, Y., Takenoya, T., ... Kitagawa, Y. (2017). A Case of Phrenic Nerve Paralysis During Adjuvant Chemotherapy for Rectal Cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 44(12), 1916-1918.

A Case of Phrenic Nerve Paralysis During Adjuvant Chemotherapy for Rectal Cancer. / Yabe, Nobushige; Tamura, Eri; Kitahama, Keiichiro; Ozawa, Hiroki; Tajima, Yuki; Takenoya, Takashi; Oto, Ippei; Yoshikawa, Takahisa; Kojima, Kenji; Murai, Shinji; Hasegawa, Hirotoshi; Kitagawa, Yuko.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 44, No. 12, 01.11.2017, p. 1916-1918.

Research output: Contribution to journalArticle

Yabe, N, Tamura, E, Kitahama, K, Ozawa, H, Tajima, Y, Takenoya, T, Oto, I, Yoshikawa, T, Kojima, K, Murai, S, Hasegawa, H & Kitagawa, Y 2017, 'A Case of Phrenic Nerve Paralysis During Adjuvant Chemotherapy for Rectal Cancer', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 44, no. 12, pp. 1916-1918.
Yabe N, Tamura E, Kitahama K, Ozawa H, Tajima Y, Takenoya T et al. A Case of Phrenic Nerve Paralysis During Adjuvant Chemotherapy for Rectal Cancer. Gan to kagaku ryoho. Cancer & chemotherapy. 2017 Nov 1;44(12):1916-1918.
Yabe, Nobushige ; Tamura, Eri ; Kitahama, Keiichiro ; Ozawa, Hiroki ; Tajima, Yuki ; Takenoya, Takashi ; Oto, Ippei ; Yoshikawa, Takahisa ; Kojima, Kenji ; Murai, Shinji ; Hasegawa, Hirotoshi ; Kitagawa, Yuko. / A Case of Phrenic Nerve Paralysis During Adjuvant Chemotherapy for Rectal Cancer. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2017 ; Vol. 44, No. 12. pp. 1916-1918.
@article{1934d963e25c4246ac1e7d2d28b7137e,
title = "A Case of Phrenic Nerve Paralysis During Adjuvant Chemotherapy for Rectal Cancer",
abstract = "A man aged 66 years presented with pneumaturia as a major complaint. Cancer of the sigmoid colon with infiltration to the urinary bladder was diagnosed and the patient underwent colectomy of the sigmoid colon and partial cystectomy of the bladder in May 2015. Histopathologic examinations revealed pT4b, Si(bladder), pN(-), cM0, fStage II . Because intestinal sub-obstruction and lymphatic invasion were present, CapeOX was administered as an adjunctive chemotherapy for the high-risk Stage II cancer. Because Grade 2 peripheral neuropathy appeared as a side effect, the dose was decreased to 80{\%} from the 3 cycle. After the 7 cycle, cough and disturbed breathing appeared. The chest CT scans did not reveal drug-induced interstitial pneumonia, but indicated an elevated right diaphragm and zosteroid changes in the medial lobe of the right lung due to discoid atelectatic condition. The Grade 1 respiratory symptoms were mild, and the lung field was considered to exhibit no problems. Thus, the 8 cycle was administered. The symptoms disappeared after about 2 weeks following completion of oral administration of capecitabine. The diaphragm also recovered to its original height. In the attached document, the frequency is unknown and {"}dyspnea{"} is written for L-OHP and capecitabine, respectively. It is unknown whether phrenic nerve paralysis occurs. However, because other organic lesions were absent and the symptoms appeared during chemotherapy, the possibility is not deniable. At present, 2 years postoperatively, recurrent lesions in the mediastinum and recurrent respiratory difficulties are absent. Generally, although phrenic nerve paralysis is not considered to be a specific side effect, it was considered that for respiratory difficulties, CT reveals not only the affected condition in the lung fields, but is also useful for detection.",
author = "Nobushige Yabe and Eri Tamura and Keiichiro Kitahama and Hiroki Ozawa and Yuki Tajima and Takashi Takenoya and Ippei Oto and Takahisa Yoshikawa and Kenji Kojima and Shinji Murai and Hirotoshi Hasegawa and Yuko Kitagawa",
year = "2017",
month = "11",
day = "1",
language = "English",
volume = "44",
pages = "1916--1918",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "12",

}

TY - JOUR

T1 - A Case of Phrenic Nerve Paralysis During Adjuvant Chemotherapy for Rectal Cancer

AU - Yabe, Nobushige

AU - Tamura, Eri

AU - Kitahama, Keiichiro

AU - Ozawa, Hiroki

AU - Tajima, Yuki

AU - Takenoya, Takashi

AU - Oto, Ippei

AU - Yoshikawa, Takahisa

AU - Kojima, Kenji

AU - Murai, Shinji

AU - Hasegawa, Hirotoshi

AU - Kitagawa, Yuko

PY - 2017/11/1

Y1 - 2017/11/1

N2 - A man aged 66 years presented with pneumaturia as a major complaint. Cancer of the sigmoid colon with infiltration to the urinary bladder was diagnosed and the patient underwent colectomy of the sigmoid colon and partial cystectomy of the bladder in May 2015. Histopathologic examinations revealed pT4b, Si(bladder), pN(-), cM0, fStage II . Because intestinal sub-obstruction and lymphatic invasion were present, CapeOX was administered as an adjunctive chemotherapy for the high-risk Stage II cancer. Because Grade 2 peripheral neuropathy appeared as a side effect, the dose was decreased to 80% from the 3 cycle. After the 7 cycle, cough and disturbed breathing appeared. The chest CT scans did not reveal drug-induced interstitial pneumonia, but indicated an elevated right diaphragm and zosteroid changes in the medial lobe of the right lung due to discoid atelectatic condition. The Grade 1 respiratory symptoms were mild, and the lung field was considered to exhibit no problems. Thus, the 8 cycle was administered. The symptoms disappeared after about 2 weeks following completion of oral administration of capecitabine. The diaphragm also recovered to its original height. In the attached document, the frequency is unknown and "dyspnea" is written for L-OHP and capecitabine, respectively. It is unknown whether phrenic nerve paralysis occurs. However, because other organic lesions were absent and the symptoms appeared during chemotherapy, the possibility is not deniable. At present, 2 years postoperatively, recurrent lesions in the mediastinum and recurrent respiratory difficulties are absent. Generally, although phrenic nerve paralysis is not considered to be a specific side effect, it was considered that for respiratory difficulties, CT reveals not only the affected condition in the lung fields, but is also useful for detection.

AB - A man aged 66 years presented with pneumaturia as a major complaint. Cancer of the sigmoid colon with infiltration to the urinary bladder was diagnosed and the patient underwent colectomy of the sigmoid colon and partial cystectomy of the bladder in May 2015. Histopathologic examinations revealed pT4b, Si(bladder), pN(-), cM0, fStage II . Because intestinal sub-obstruction and lymphatic invasion were present, CapeOX was administered as an adjunctive chemotherapy for the high-risk Stage II cancer. Because Grade 2 peripheral neuropathy appeared as a side effect, the dose was decreased to 80% from the 3 cycle. After the 7 cycle, cough and disturbed breathing appeared. The chest CT scans did not reveal drug-induced interstitial pneumonia, but indicated an elevated right diaphragm and zosteroid changes in the medial lobe of the right lung due to discoid atelectatic condition. The Grade 1 respiratory symptoms were mild, and the lung field was considered to exhibit no problems. Thus, the 8 cycle was administered. The symptoms disappeared after about 2 weeks following completion of oral administration of capecitabine. The diaphragm also recovered to its original height. In the attached document, the frequency is unknown and "dyspnea" is written for L-OHP and capecitabine, respectively. It is unknown whether phrenic nerve paralysis occurs. However, because other organic lesions were absent and the symptoms appeared during chemotherapy, the possibility is not deniable. At present, 2 years postoperatively, recurrent lesions in the mediastinum and recurrent respiratory difficulties are absent. Generally, although phrenic nerve paralysis is not considered to be a specific side effect, it was considered that for respiratory difficulties, CT reveals not only the affected condition in the lung fields, but is also useful for detection.

UR - http://www.scopus.com/inward/record.url?scp=85046476803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046476803&partnerID=8YFLogxK

M3 - Article

C2 - 29394819

AN - SCOPUS:85046476803

VL - 44

SP - 1916

EP - 1918

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 12

ER -